News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
28
2023
-
04
Heavy | Linuo Pharmaceutical and Beijing Nuokangda Pharmaceutical signed a strategic cooperation agreement
Classification：
Corporate News
On the morning of April 26, the strategic cooperation signing ceremony between Beijing Nuokangda Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Nuokangda Pharmaceutical) and Shandong Linuo Pharmaceutical Co., Ltd. (hereinafter referred to as Linuo Pharmaceutical) was held in Jinan. Tao Xiumei, general manager of Nuokangda Pharmaceuticals, Gao Yuankun, chairman and president of Linuo Group, and Jiang Hongsheng, general manager of Linuo Pharmaceuticals, attended the signing ceremony.
Before the signing ceremony, Nuokangda Pharmaceutical Tao Xiumei and his party visited the exhibition hall of Linuo Group. Jiang Hongsheng, general manager of Linuo Pharmaceutical, introduced the company's development history, product layout and cultural concept in detail. Afterwards, the two sides held a discussion at the Panama Business Center.
Tao Xiumei mentioned that Nuokangda Pharmaceutical is a national high-tech enterprise focusing on the research of innovative preparation technology. The concept of "running in small steps and doing it right at the first time" has obvious advantages in the fields of raw materials, generic drugs, innovative drugs, and medical devices.
Gao Yuankun, chairman and president of Linuo Group, said that Nuokangda Pharmaceutical has a high degree of fit with Linuo Pharmaceutical in terms of corporate development planning and product core competitiveness. Linuo Pharmaceutical is a well-known pharmaceutical production and sales enterprise in China. The main raw materials of its products come from its parent company, Keyuan Pharmaceutical (stock code 301281). Keyuan Pharmaceutical provides stable and high-quality raw material support and guarantee for Linuo Pharmaceutical. In the future, Linuo Pharmaceutical will give full play to the synergistic advantages of the integration of raw materials and preparations, and strive to become a first-class chemical drug manufacturing service provider in China.
After discussions and exchanges, the two sides agreed that the technology research and development level and high-efficiency conversion capabilities of Nuo Kangda Pharmaceuticals and the strong market foundation and production and operation capabilities of Linuo Pharmaceuticals can form complementary advantages. Based on the principles of friendly consultation and mutual benefit, the two parties signed a strategic cooperation framework agreement.
Tao Xiumei, general manager of Nuo Kangda Pharmaceuticals, and Jiang Hongsheng, general manager of Linuo Pharmaceuticals, signed the contract on behalf of both parties.
In the future, the two parties will carry out in-depth exchanges and cooperation in product selection and cultivation, high-level talent introduction and exchange, R&D and operation platform construction, etc., give full play to their respective advantages, share resources, and work together to achieve better results in the overall situation of high-quality development develop.
Related news
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China
